Immunome
We are a clinical-stage oncology company committed to developing best-in-class ADCs as well as other targeted therapies that improve outcomes for cancer patients.
We are a clinical-stage oncology company committed to developing best-in-class ADCs as well as other targeted therapies that improve outcomes for cancer patients.